US EditionPublished • loading... • Updated
Novel Drug Led to Meaningful Weight Loss in Adults With Obesity
Eloralintide led to 20.1% average weight loss and improved health markers in 263 patients during an 11-month Phase 2 trial, with Phase 3 enrollment starting next month.
Summary by MedPage Today
3 Articles
3 Articles
MedPage TodayReposted by 
Anti-Aging, Acupuncture and Health News
Anti-Aging, Acupuncture and Health NewsNovel Drug Led to Meaningful Weight Loss in Adults With Obesity
(MedPage Today) -- Subcutaneous injections of an investigational, selective long-acting amylin receptor agonist led to clinically meaningful reductions in body weight among adults with obesity, a phase II randomized trial showed. The mean percent...
·New York, United States
Read Full ArticleCoverage Details
Total News Sources3
Leaning Left1Leaning Right0Center1Last UpdatedBias Distribution50% Left, 50% Center
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
50% Center
L 50%
C 50%
Factuality
To view factuality data please Upgrade to Premium
